Advertisement
Quick Menu

Upcoming Journals

International Journal of TROPICAL DISEASE & Health

International Journal of TROPICAL DISEASE & Health, ISSN: 2278-1005,Vol.: 5, Issue.: 3

 

Original Research Article

 

In vitro Antiplasmodial, Antitrypanosomal, Antileishmanial and Cytotoxic Activities of Various Fractions of Abrus precatorius Leaf

 

 

Saganuwan Alhaji Saganuwan1*, Patrick Azubuike Onyeyili1, Igoche George Ameh2, Ngozi Justina Nwodo3 and Reto Brun4

1Department of Veterinary Physiology, Pharmacology and Biochemistry, College of Veterinary Medicine, University of Agriculture, P.M.B. 2373, Makurdi, Benue State, Nigeria.
2Department of Parasitology and Medical Microbiology, College of Health Sciences, Usmanu Danfodiyo University, P.M.B. 2254, Sokoto, Sokoto State, Nigeria.
3Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Nigeria Nsukka, Enugu State, Nigeria.
4Swiss Tropical and Public Health Institute, Basel, Switzerland.

 

Abstracts

 

Background: Infectious diseases are the worst problem in tropical and subtropical regions of the world. The Nupe ethnic group from Nigeria has been using the leaves of Abrus precatorius for treatment of malaria and various forms of cancers. However studies have shown that the plant has antimicrobial and anti-cancer activities. In this study the crude methanolic extract, methanolic, ethyl acetate, chloroform and n-hexane fractions of Abrus precatorius leaf were tested In vitro against chloroquine and pyrimethamine resistant Plasmodium falciparum K1, Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovoni and rat skeletal myoblasts (L-6 cells).
Methods: The leaf ingredients were extracted and separated via methanol, ethyl acetate, chloroform and n-hexane solvents using column chromatography. In vitro activity against erythrocytic stages of P. falciparum was determined by a modified [3H]-hypoxanthine incorporation assay. In vitro activities against T. brucei rhodesiense, T. cruzi and L. donovoni and cytotoxicity against L6 cells line were assayed. Regression analysis was adopted for computation of the 50% inhibitory concentrations. The antiprotozoan activity of the extracts was qualified as active when IC50 value was less than 50 μg/ml. The extract that showed selectivity index higher than 3.29 was considered to have potential for safer therapy.
Results: n-hexane fraction showed the best antiplasmodial activity with inhibitory concentration (IC50) value of 12.1 μg/ml followed by chloroform fraction (23.0 μg/ml), crude methanolic extract (30.4 μg/ml) and ethyl acetate fraction (45.9 μg/ml) with selectivity index of 3.66, 1.90, 2.18 and 3.29 respectively. Chloroform fraction showed the best activity against T. brucei rhodesiense with IC50 value of 17.9 μg/ml and selectivity index of 2.44 and followed by n-hexane fraction with IC50 (34.5 μg/ml) and selectivity index of 1.28.
Conclusion: Since leaf extract has significant antiplasmodial, antitrypanosomal and antileshmanial activities in vitro, bioassay guided isolation of the active principles can be done with a view to discovering novel drugs for the treatment of malaria, trypanosomiasis and leishmaniasis.

 

Keywords :

Abrus precatorius; cytotoxicity; Plasmodium falciparum; Leishmania donovoni; Trypanosoma species; fractionation.

 

Full Article - PDF    Page 221-229    Article Metrics

 

DOI : 10.9734/IJTDH/2015/13683

Review History    Comments

Search this site

Advanced Search

Announcement & News

ISI Thomson Reuters selected British Journal of Pharmaceutical Research for Emerging Sources Citation Index

We are delighted to inform that ISI Thomson Reuters selected British Journal of Pharmaceutical Resea...

SCOPUS selected Annual Research & Review in Biology (ARRB)

We are delighted to inform that famous indexing organization SCOPUS (from Elsevier) selected  A...

Index Copernicus Evaluation Result Released

We are delighted to inform that Index Copernicus (a leading indexing organization from Pol...

Journal Repository (JR): Permanent Digital Archiving of SDI journals

SDI is happy to announce that all our journals are now permanently archived in Journal Repository (J...

SDI journal got 35th ranking in Publons

We are delighted to announce (as of 04/01/2016) that British Journal of Medicine and Medical Re...

Growth of SDI and world publication market

As of 2014, total 25,064 journals are competing in World market of journal publication. In 2011, tot...

Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (Bri...

SDI introduced Post-publication peer review by its comment section

SDI journals encourage Post-publication peer review by its comment section   Policy details a...

SDI promotes transparent Advanced OPEN peer review

We have migrated to transparent and toughest ‘Advanced OPEN peer review’ system (...



SCIENCEDOMAIN Awards

  • No Awards listed.

Browser Compatibility : Mozila firefox, Google Crome and IE 7 & above. Creative Commons License Terms & Condition   |   Privacy Policy   |   Join Us   |   Help   |   Contact Us
© Copyright 2010-2018, SCIENCEDOMAIN international. All rights reserved.